AVITA Medical, Inc.
RCEL
$4.07
$0.164.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.52% | 21.44% | 15.29% | -3.50% | -27.28% |
| Total Depreciation and Amortization | 66.20% | 103.73% | 127.43% | 136.41% | 106.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.87% | -29.48% | 63.99% | 200.39% | 334.70% |
| Change in Net Operating Assets | -46.52% | 173.51% | 65.84% | 100.76% | 119.06% |
| Cash from Operations | 19.35% | 36.26% | 34.58% | 33.00% | 22.93% |
| Capital Expenditure | 90.26% | 89.04% | 58.10% | -33.07% | -267.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.03% | -71.08% | 225.05% | 1,079.23% | 31,675.38% |
| Cash from Investing | -88.73% | -66.67% | 166.54% | 443.65% | 1,664.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 382.44% | 355.93% | 431.11% | 7.27% | 56.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 537.96% | 325.77% | -62.53% | -92.89% | -92.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -215.28% | 52.81% | 90.01% | 73.86% | 81.25% |